1IA
PFE icon

1620 Investment Advisors’s Pfizer PFE Stock Holding History

1620 Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$869K Sell
36,100
-638
-2% -$16.7K 0.54% 43
2026
Q1 		$1.03M Buy
36,738
+371
+1% +$9.88K 0.7% 32
2025
Q4 		$906K Sell
36,367
-4,098
-10% -$103K 0.6% 42
2025
Q3 		$1.03M Buy
40,465
+2,229
+6% +$55K 0.7% 34
2025
Q2 		$927K Buy
38,236
+19,516
+104% +$455K 0.66% 36
2025
Q1 		$474K Buy
18,720
+629
+3% +$16.5K 0.36% 85
2024
Q4 		$480K Sell
18,091
-1,093
-6% -$29.6K 0.36% 86
2024
Q3 		$555K Sell
19,184
-145
-0.8% -$4.23K 0.4% 76
2024
Q2 		$541K Buy
19,329
+18,544
+2,362% +$511K 0.41% 66
2024
Q1 		$516K Sell
785
-17,821
-96% -$495K 0.52% 62
2023
Q4 		$536K Buy
18,606
+310
+2% +$9.37K 0.59% 56
2023
Q3 		$607K Buy
18,296
+6
+0% +$212 0.69% 43
2023
Q2 		$671K Buy
18,290
+189
+1% +$7.36K 0.73% 43
2023
Q1 		$739K Buy
18,101
+26
+0.1% +$1.12K 0.89% 35
2022
Q4 		$926K Buy
18,075
+104
+0.6% +$4.99K 1.12% 24
2022
Q3 		$786K Buy
17,971
+144
+0.8% +$7K 1.16% 25
2022
Q2 		$935K Buy
17,827
+525
+3% +$26.8K 1.29% 22
2022
Q1 		$1.02M Hold
17,302
– – 1.11% 27
2021
Q4 		$1.02M Buy
+17,302
New +$857K 1.14% 27

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

1620 Investment Advisors's PFE Position: Q2 2026 in Review

1620 Investment Advisors reduced its Pfizer (PFE) stake by 1.7% in Q2 2026, selling an estimated $16.7K and leaving 36,100 shares worth $869K. The position accounts for 0.54% of the portfolio, ranked #43.

1620 Investment Advisors first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.03M in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • 1620 Investment Advisors held 36,100 shares of Pfizer worth $869K as of Q2 2026.
  • 1620 Investment Advisors sold 638 Pfizer shares in Q2 2026, an estimated $16.7K.
  • Pfizer made up 0.54% of 1620 Investment Advisors's portfolio in Q2 2026, its #43 holding.
  • 1620 Investment Advisors first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • 1620 Investment Advisors's Pfizer position peaked at $1.03M in Q1 2026.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on 1620 Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.